Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study

被引：0
|
作者：
Belén Sádaba
Jose Ramón Azanza
Aintzane García-Bea
Luis Labeaga
Cristina Campo
Román Valiente
机构：
[1] Clínica Universidad de Navarra,Clinical Pharmacology Service
[2] IdiSNA,Medical Department
[3] Navarra Institute for health Research,Clinical Research Department
[4] Faes Farma S. A.,undefined
[5] Faes Farma S. A.,undefined
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2020年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 272
页数：7
相关论文
共 50 条
  • [31] Pharmacokinetics and safety of transdermal and oral granisetron in healthy Chinese subjects: An open-label, randomized, crossover study
    Chen, Rui
    Chen, Xia
    Wang, Hongyun
    Zhong, Wen
    Oh, Eun Sil
    Park, Min Soo
    Kumagai, Yuji
    Zhou, Li
    Nagahama, Fumiko
    Hu, Pei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (01) : 24 - 31
  • [32] Bioequivalence Evaluation of 2 Tablet Formulations of Entecavir in Healthy Chinese Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study
    Jin, J.
    Liu, J.
    Chen, J.
    Zhao, L.
    Ma, Z.
    Chen, X.
    Huang, M.
    Zhong, G.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (03): : 113 - 116
  • [33] Bioequivalence Study with Two Different Oral Formulations of Methocarbamol in Healthy Subjects
    Schlegelmilch, Ronald
    Eydeler, A. Urte
    Barkworth, Martin
    Radeke, Anika
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2009, 59 (05): : 238 - 242
  • [34] Bioequivalence evaluation of three different oral formulations of ciprofloxacin in healthy volunteers
    Maya, MT
    Gonçalves, NJ
    Silva, NE
    Filipe, AE
    Morais, JA
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2003, 28 (02) : 129 - 136
  • [35] Bioequivalence evaluation of three different oral formulations of ciprofloxacin in healthy volunteers
    Manuela T. Maya
    Nuno J. Gonçalves
    Nuno E. Silva
    Augusto E. Filipe
    José A. Morais
    European Journal of Drug Metabolism and Pharmacokinetics, 2003, 28 : 129 - 136
  • [36] Evaluation of the Effect of Food and Age on the Pharmacokinetics of Oral Netupitant and Palonosetron in Healthy Subjects: A Randomized, Open-Label, Crossover Phase 1 Study
    Calcagnile, Selma
    Lanzarotti, Corinna
    Gutacker, Michaela
    Jakob-Rodamer, Verena
    Kammerer, Klaus Peter
    Timmer, Wolfgang
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (05): : 377 - 386
  • [37] Bioequivalence of a New Pediatric Paracetamol Oral Suspension Compared With a Marketed Formulation in Healthy Adults: A Randomized, Open-Label Study
    Grim, Jiri
    Armogida, Marianna
    Kachroo, Preeti
    Siddiqui, Kamran
    Cavinato, Mauro
    Araga, Mako
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2024, 100
  • [38] Bioequivalence study of the antiepileptic drug levetiracetam in concentrated solution for injection versus oral tablets in healthy Chinese subjects under fasting conditions: A randomized, open-label, three-way crossover study
    Xu, Junyu
    Zhao, Xia
    Wang, Zining
    Zhou, Ying
    Yang, Xiaoqin
    Cui, Yimin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (11) : 555 - 561
  • [39] Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects
    Feifei Sun
    Yanping Liu
    Ting Li
    Pingping Lin
    Xin Jiang
    Xin Li
    Chenjing Wang
    Xiaomeng Gao
    Yaping Ma
    Yao Fu
    Yu Cao
    BMC Pharmacology and Toxicology, 24
  • [40] Bioequivalence and Tolerability of Two Clopidogrel Salt Preparations, Besylate and Bisulfate: A Randomized, Open-Label, Crossover Study in Healthy Korean Male Subjects
    Kim, Sung-Doo
    Kang, Wonku
    Lee, Hae Won
    Park, Dae Jin
    Ahn, Ju Hee
    Kim, Mi Jin
    Kim, Eun Young
    Kim, SungWuk
    Nam, Hee Sook
    Na, Hye Jung
    Yoon, Young-Ran
    CLINICAL THERAPEUTICS, 2009, 31 (04) : 793 - 803
12345